Dr. Pan-Chyr Yang
Independent Director since June 2023
Chairman, Remuneration Committee
Member, Audit Committee & Risk Management Committee
Specialty in Consumer Staples & Healthcare sectors*
Dr. Pan-Chyr Yang is currently a professor at the Department of Internal Medicine, College of Medicine, National Taiwan University, and Academician of Academia Sinica. He is also the Vice President of the Institute for Biotechnology and Medicine Industry, and a Juristic-Person Director at Microbio since 2021. Dr. Yang is a world-renowned lung cancer researcher, and has advocated for smart medicine and building a sustainable big-data platform for precision health in recent years.
Dr. Yang is a pioneer in his field as he has successfully applied ultrasound technology to the diagnosis of chest diseases. Since the early 2000s, he has conducted advanced research for female lung cancer in Taiwan and his work has been published in various international journals since then. During the pandemic, Dr. Yang and his team developed the ACE2-Fc decoy antibody to block virus infection, with their work being published by EMBO Molecular Medicine.
Dr. Yang holds a Ph.D. from the National Taiwan University’s Graduate Institute of Clinical Medicine and was appointed President of National Taiwan University from 2013 to 2017. He was a recipient of the 1993 Ten Outstanding Youth Award in Taiwan along with multiple Outstanding Research Awards from the National Science Council.
* Specialty sectors according to the Global Industry Classification Standard (GICS) classification, jointly developed by MSCI and the S&P Dow Jones Indices.